Dr Agarwal’s Healthcare IPO opens for subscription as GMP remains muted. Should you subscribe?

January 29, 2025

Dr Agarwal’s Healthcare IPO is now open for subscription, with a price range of Rs 382-402 per share. Despite a significant OFS component and rich pricing, analysts recommend investing for the long term. The company commands a 25% market share in India’s eye care service market, benefiting from industry growth projections.

More To Explore

Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25

Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected

January 30, 2025

Tech view: Nifty shows strength; 23,000 support key for buy-on-dips. How to trade tomorrow

Nifty closed positively at 23,250, with India VIX dropping 6.7%, indicating lower volatility. Analysts see support at 23,000 and resistance at 23,340-23,500, favoring a buy-on-dips

January 30, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003